Author Information
Claus Michael Lehr is an esteemed researcher affiliated with the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), part of the Helmholtz Centre for Infection Research (HZI), and Saarland University. His work is conducted at the Universitätscampus E8.1, 66123 Saarbrücken, Germany. Additionally, he is associated with the Department of Pharmacy at Saarland University.Research Contributions
Claus Michael Lehr has made significant contributions to the field of nanotechnology, particularly in the context of pharmaceutical research and drug delivery systems. His recent works in 2022 include research on models using native tracheobronchial mucus for pulmonary drug delivery, development of nano-in-microparticles for targeted aerosol delivery of antibiotics, and targeting Pseudomonas aeruginosa with glycomimetic liposomes. He has also explored the leaky gut model for testing siRNA-based nanomedicine targeting JAK1. His 2021 publications further demonstrate his involvement in developing innovative solutions for combating bacterial infections, such as pulmonary mucus surrogates and transdermal nanogels, and his focus on creating more predictive, physiological, and animal-free in vitro models.Aliases
Claus Michael Lehr is known by several aliases, including Claus-m. Lehr, Claus M. Lehr, Claus-m Lehr, Claus M Lehr, Claus-michael Lehr, C -m. Lehr, C.-m. Lehr, C M Lehr, Claus-michael Lehr, C Michael Lehr, Claus Michael Lehr, and C Lehr. These variations are commonly found in his publications and professional references.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
24,580 |
| H-index |
84 |
| Total Number of Papers |
540 |
